Tagged: univeral access
Inadequate donor financing and aggressive tactics by multinational pharmaceutical companies threaten to derail efforts to achieve universal access to HIV/AIDS prevention, care, treatment and support by 2010.
GROW reports and papers
GROW has many partners around the world. Learn more about whom we're working with.